Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

25 Oct 2007 07:00

Embargoed Release: 07:00hrs, Thursday 25 October 2007

SOPHEON PLC ("Sopheon") TRADING UPDATE Sopheon, the international provider of software and services that improve thefinancial return from innovation and product development investments issues atrading update.Since the mid year, we have divided our effort between our core pipeline, theadditional pipeline resulting from our acquisition of Alignent Software and thecustomer conversion opportunities stemming from our recently announcedagreement with IDe. During that period we added three new customers for ourAccolade solution and three for Vision Strategist, the product acquired withAlignent. We also closed six extension orders within the combined customerbase. This activity brings the total number of customers licensing Sopheonsoftware to 131, up from 87 upon entering 2007. The total of 131 is representedby 99 for the Sopheon platform and 35 for the Alignent platform, of which 3 arealso Accolade users.The Alignent and IDe transactions, although somewhat disruptive over the summermonths, have substantially strengthened Sopheon's market position and businessprospects. Most of the core integration activities associated with ouracquisition of Alignent are now behind us. People, facilities, and resourceswere successfully integrated in the third quarter. In addition to the new salesnoted above, we expect to renew all but one of Alignent's recurring maintenanceand license contracts that were due for renewal between the acquisition dateand year-end, underlining the strong business value of the Vision Strategistproduct.In parallel with commercial activities, we have continued to invest heavily inproduct development. In September, our development team released a new versionof Vision Strategist to the market. In the third quarter we announced that anintegration of the portfolio management capabilities of our Accolade solutionwith Vision Strategist, and made the integrated solution available forpurchase. Initial orders are expected in the fourth quarter. Looking forward,we are on track to introduce the most significant new release of our Accoladesolution in our history. Scheduled for introduction at the end of the year,this release will extend the value and functionality of Sopheon's software forthe non-process manufacturing markets, including the large aerospace, defenceand automobile sectors. As part of this release we will also be introducing anew version of Vision Strategist. The combination will be the first in theindustry to integrate product planning and product development execution, andis expected to have immediate impact on our business development efforts.In August we announced that we had entered into an exclusive agreement to offertransitional services to the customers of IDe, a former Sopheon competitor. Wehave since contacted all of IDe's customers, and three have already signedagreements to adopt Accolade. This will drive maintenance and services revenuein the short term, and possible license extension orders in the medium term.The initial services engagements were kicked off in early October. Twoadditional customers have signed letters-of-intent, indicating a desire to workwith Sopheon moving forward. We remain in discussion with a handful of others.Contracted and recurring revenue visibility for 2007 stands at ‚£5.8m. We haveoften noted the influence that the timing of individual sales can have on ourresults, and achieving our objectives for the year will remain challenging;however, in our interim statement we also noted that our sales funnel wasrobust, with a number of potentially large deals in the prospect population,and this remains the case. Subject to the above, the current high levels ofactivity in our pipeline, coupled with existing visibility, give us continuedconfidence that our full-year performance for 2007 will show substantialimprovement over 2006. -Ends-

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Andrew Tan Hansard Communications Tel : + 44 (0) 207 245 1100 + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 David Newton Seymour Pierce Tel : + 44 (0) 207 107 8000About SopheonSopheon is an international provider of software and services thathelp organizations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.